Viking Therapeutics target price raised to $118 from $106 by Canaccord Genuity
VKTX•Canaccord Genuity raised its target price for Viking Therapeutics to $118 from $106.
Related News
Boston Scientific Corporation: UBS cuts target price to $57 from $67
BSX•
C.H. Robinson Worldwide target price cut to $204 from $230
CHRW•
Truist grants CEO Michael Lyons 351,941 restricted stock units
TFC•
US research roundup: Baker Hughes, Brinker International, GE Vernova
GEV•
SiteOne Landscape Supply raises target price to $122 from $110
SITE•